Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Mats Bojestig"'
Autor:
Anette Peterson, Lena Hanberger, Karin Akesson, Mats Bojestig, Boel Andersson Gäre, Ulf Samuelsson
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e97875 (2014)
Several studies show that good metabolic control is important for children and adolescents with type 1 diabetes. In Sweden, there are large differences in mean haemoglobin A1c (HbA1c) in different hospitals and difficulties implementing national guid
Externí odkaz:
https://doaj.org/article/1ec98c63bf30449cb580c734785fe5ff
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 2:458-464
Background— The Swedish quality improvement initiative Quality Improvement in Coronary Care previously demonstrated significant improvements in caregiver adherence to national guidelines for acute myocardial infarction. The associated impact on 1-y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f8895b276ab74e739ed8ac26ba736f7
https://doi.org/10.1161/circoutcomes.108.842146
https://doi.org/10.1161/circoutcomes.108.842146
Publikováno v:
Quality Management in Health Care. 16:10-15
Over the past 10 years, Jönköping County in Sweden has made impressive progress in improving its health care system. The motor of improvement work is Qulturum, an innovation and learning center within the health system. Qulturum has no responsibili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68134127f5b35fb6d2832ecddb04af99
https://doi.org/10.1097/00019514-200701000-00003
https://doi.org/10.1097/00019514-200701000-00003
Autor:
Gunilla Lindström, Anette Peterson, Christina Åberg, Boel Andersson-Gäre, Mats Bojestig, Rickard Carlhed, Bertil Lindahl
Publikováno v:
Quality Management in Health Care. 16:25-37
Data from the Swedish National Register in Cardiac Care have shown over the last 10 years an enduring gap between optimal treatment of acute myocardial infarction (AMI) according to current guidelines and the treatment actually given. We performed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da804887326fad34135f596d86d4d63f
https://doi.org/10.1097/00019514-200701000-00005
https://doi.org/10.1097/00019514-200701000-00005
Autor:
Anette Peterson, Johan Thor, Soffia Gudbjörnsdottir, Ulla-Britt Löfgren, Boel Andersson Gäre, Linus Schiöler, Mats Bojestig
Publikováno v:
Quality management in health care. 24(4)
Since 1996, the Swedish National Diabetes Register (NDR) enabled health care providers to monitor their clinical performance over time and compare it with the national average. All health systems of Swedish county councils report data. By 2014, the N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d85549ff0f7e794ecbb0d84f23c23007
https://pubmed.ncbi.nlm.nih.gov/26426323
https://pubmed.ncbi.nlm.nih.gov/26426323
Autor:
Christina Åberg, Anette Peterson, Lars Wallentin, Gunilla Lindström, Rickard Carlhed, Bertil Lindahl, Mats Bojestig
Publikováno v:
American Heart Journal. 152:1175-1181
Background The adherence to evidence-based treatment guidelines for acute myocardial infarction (AMI) is still suboptimal. Therefore, we designed a study to evaluate the effects of a collaborative quality improvement (QI) intervention on the adherenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1fca2ac421d360df74dfb91cb934e5d
https://doi.org/10.1016/j.ahj.2006.07.028
https://doi.org/10.1016/j.ahj.2006.07.028
Autor:
Karin Åkesson, Boel Andersson Gäre, Ulf Samuelsson, Lena Hanberger, Anette Peterson, Mats Bojestig
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 5, p e97875 (2014)
PLoS ONE, Vol 9, Iss 5, p e97875 (2014)
Background Several studies show that good metabolic control is important for children and adolescents with type 1 diabetes. In Sweden, there are large differences in mean haemoglobin A1c (HbA1c) in different hospitals and difficulties implementing na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c110bfcee430baca89c61536e1adb01c
http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-25619
http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-25619
Publikováno v:
Diabetes Care. 24:919-924
OBJECTIVE—To study whether administration of 1.25 and 5.0 mg ramipril daily, compared with placebo treatment, reduces the urinary albumin excretion rate (UAER) in normotensive patients with type 1 diabetes. RESEARCH DESIGN AND METHODS—Ramipril wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00af9e215f9eb555a29bce86a6e2eab6
https://doi.org/10.2337/diacare.24.5.919
https://doi.org/10.2337/diacare.24.5.919
Publikováno v:
Journal of the Renin-Angiotensin-Aldosterone System, Vol 1 (2000)
Europe PubMed Central
Europe PubMed Central
Poor glycaemic control and high blood pressure are two important risk factors for the development of retinopathy and nephropathy in Type 1 diabetes. The renin-angiotensin-aldosterone system (RAAS) may be involved in this process, since treatment with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd242f1a3480f30d5cf9cdc2a1d527b
https://doi.org/10.3317/jraas.2000.065
https://doi.org/10.3317/jraas.2000.065
Publikováno v:
Diabetic Medicine. 15:863-869
The incidence of nephropathy in Type 1 diabetes mellitus has declined during the past decade, probably as a result of improved glycaemic control. We wanted to investigate whether the incidence of severe retinopathy has changed during the same time pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::786aee1c30ff38623ca5a9154598826a
https://doi.org/10.1002/(sici)1096-9136(199810)15:10<863::aid-dia665>3.0.co
https://doi.org/10.1002/(sici)1096-9136(199810)15:10<863::aid-dia665>3.0.co